Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease

Heather Carney; Ruth Ann Marrie; James M. Bolton; Scott Burton Patten; Lesley A. Graff; Çharles N. Bernstein; Kaarina Kowalec

doi:10.1093/ibd/izaa014

Abstract

1 min read

One in six persons with IBD experienced an SUD, suggesting that clinicians should maintain high index of suspicion regarding possible SUD, and inquiries about substance use should be a part of care for IBD patients, particularly for men, smokers, and patients with anxiety disorders and pain.

Related publications

Article2021

The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis

Daniel J. Devoe, Gina Dimitropoulos, Alida Anderson, Anees Bahji, Jordyn Flanagan, Andrea Soumbasis, Scott Burton Patten, Tom Lange, Georgios Paslakis

Article2008

Bulimia Nervosa and Substance Use Disorder: Similarities and Differences

Alpana Ram, Dan Joseph Stein, Sivan Sofer, Shulamith Kreitler

Article2017

Cognitive orientation in substance use disorders and chronic cigarette smoking

Dan Joseph Stein, Anca Ram, Sivan Sofer, Shulamith Kreitler

Article2022

Use of Benzodiazepines and Z-Drugs in Inflammatory Bowel Disease

Çharles N. Bernstein, John D. Fisk, Randy Walld, James M. Bolton, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, Renée El‐Gabalawy, Lesley A. Graff, Alan Katz, Kelcie Witges, James Marriott, Ruth Ann Marrie

Article2023

Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel Disease

Çharles N. Bernstein, Casandra Dolovich, Madelaine Prichodko, John D. Fisk, Lesley A. Graff, Scott Burton Patten, James M. Bolton, Carol Hitchon, Ruth Ann Marrie